Urinary Tract Infection Complicated
7 clinical trials · Condition
◉ Watch Urinary Tract Infection Complicated
| Record | Firm | Date |
|---|---|---|
| Safety and Efficacy of ZTI-01 (IV Fosfomycin) vs Piperacillin/Tazobactam for Treatment cUTI/AP Infections (NCT02753946) | Nabriva Therapeutics AG | 2016-04-01 |
| Efficacy/Safety of Meropenem-Vaborbactam Compared to Piperacillin-Tazobactam in Adults With cUTI and AP (NCT02166476) | Melinta Therapeutics, Inc. | 2014-11-20 |
| Efficacy, Safety, Tolerability of Vabomere Compared to Best Available Therapy in Treating Serious Infections in Adults (NCT02168946) | Rempex (a wholly owned subsidiary of Melinta Therapeutics, Inc.) | 2014-07-01 |
| Study of Cases of Serious Infections Due to Carbapenem-Resistant Enterobacteriaceae (NCT02420366) | Rempex (a wholly owned subsidiary of Melinta Therapeutics, Inc.) | 2014-05-01 |
| CSE-1034 (Ceftriaxone+ Sulbactam+ EDTA) Compared to Meropenem in Complicated Urinary Tract Infections (cUTIs) Caused by ESBL Producing Gram Negative Bacteria (NCT03477422) | Venus Remedies Limited | 2014-01-11 |
Track Urinary Tract Infection Complicated automatically
Every clearance here is in the API, with alerts when new ones post.